TrialCells2021

Plasma Biomarker Profiling in Heart Failure Patients with Preserved Ejection Fraction before and after Spironolactone Treatment: Results from the Aldo-DHF Trial.

Moritz Schnelle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.